114 related articles for article (PubMed ID: 7906245)
1. Lymphoepithelioma-like carcinoma of the uterine cervix with c-erbB-2, p53 oncoprotein expression and DNA quantification.
Walsh CB; Kay E; Prendiville W; Turner M; Leader M
Histopathology; 1993 Dec; 23(6):592-3. PubMed ID: 7906245
[No Abstract] [Full Text] [Related]
2. c-erbB-2 Oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix.
Oka K; Nakano T; Arai T
Cancer; 1994 Feb; 73(3):664-71. PubMed ID: 7905364
[TBL] [Abstract][Full Text] [Related]
3. Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content.
Prat J; Oliva E; Lerma E; Vaquero M; Matías-Guiu X
Cancer; 1994 Sep; 74(6):1778-83. PubMed ID: 7915964
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of p53 protein and c-erbB-2 protein in small cell carcinoma of the cervix uteri.
Holm R; Abeler VM; Skomedal H; Nesland JM
Zentralbl Pathol; 1993 Jun; 139(2):153-6. PubMed ID: 8103676
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors.
Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219
[TBL] [Abstract][Full Text] [Related]
6. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO
Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIB squamous cell carcinoma of the uterine cervix treated with radiation therapy alone.
Ebara T; Mitsuhashi N; Saito Y; Sakurai H; Hasegawa M; Takahashi M; Takahashi T; Hayakawa K; Niibe H
Gynecol Oncol; 1996 Nov; 63(2):216-8. PubMed ID: 8910630
[TBL] [Abstract][Full Text] [Related]
8. The relationship between expression of p53/bcl-2 and clinicopathological criteria in cervix squamous cell carcinomas.
Bitiren M; Cakmak EA; Gocmen A; Inaloz SS; Sari I; Karakok M; Aydin A
Eur J Gynaecol Oncol; 2003; 24(5):411-2. PubMed ID: 14584658
[TBL] [Abstract][Full Text] [Related]
9. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
Volm M; Efferth T; Mattern J
Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.
Hale RJ; Buckley CH; Fox H; Williams J
J Clin Pathol; 1992 Jul; 45(7):594-6. PubMed ID: 1355495
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
13. Lymphoepithelioma-like carcinoma of the uterine cervix.
Martorell MA; Julian JM; Calabuig C; García-García JA; Pérez-Vallés A
Arch Pathol Lab Med; 2002 Dec; 126(12):1501-5. PubMed ID: 12456211
[TBL] [Abstract][Full Text] [Related]
14. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix.
Chang JL; Tsao YP; Liu DW; Han CP; Lee WH; Chen SL
Gynecol Oncol; 1999 Apr; 73(1):62-71. PubMed ID: 10094882
[TBL] [Abstract][Full Text] [Related]
15. A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomas.
Kearsley JH; Leonard JH; Walsh MD; Wright GR
Pathology; 1991 Jul; 23(3):189-94. PubMed ID: 1685773
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of p53 expression in stage IB1 cervical carcinoma.
Chen HY; Hsu CT; Lin WC; Tsai HD; Chang WC
Gynecol Obstet Invest; 2000; 49(4):266-71. PubMed ID: 10828711
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of bcl-2, p53 and Ki-67 in invasive squamous carcinoma of the uterine cervix.
Padovan P; Salmaso R; Marchetti M; Padovan R
Eur J Gynaecol Oncol; 2000; 21(3):267-72. PubMed ID: 10949392
[TBL] [Abstract][Full Text] [Related]
18. p53 protein and c-erbB-2 protein (p185) expression in endometrial adenocarcinoma of endometrioid type. An immunohistochemical examination on paraffin sections.
Nielsen AL; Nyholm HC
Am J Clin Pathol; 1994 Jul; 102(1):76-9. PubMed ID: 7913577
[TBL] [Abstract][Full Text] [Related]
19. Oncoprotein c-erbB-2 in squamous cell carcinoma of the uterine cervix and evaluation of its significance in response of disease to treatment.
Bhadauria M; Ray A; Grover RK; Sharma S; Naik SL; Sharma BK
Indian J Physiol Pharmacol; 2001 Apr; 45(2):191-8. PubMed ID: 11480225
[TBL] [Abstract][Full Text] [Related]
20. Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tract.
van Dam PA; Lowe DG; Watson JV; James M; Chard T; Hudson CN; Shepherd JH
Gynecol Oncol; 1991 Sep; 42(3):256-64. PubMed ID: 1683331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]